The 2025 edition of the Health Research call from the “la Caixa” Foundation has selected 34 new cutting-edge biomedical research…
Fundació ‘la Caixa’
Reported at the European Society for Medical Oncology (ESMO) Congress 2025 in Berlin, Germany, results from four multicenter early phase…
”la Caixa” Foundation has announced the results of the 2025 CaixaImpulse program, supporting 31 biomedical projects from research centers, hospitals,…
Presented at the 2025 American Society of Clinical Oncology (ASCO) Annual Meeting* by Jaume Capdevila, a Medical Oncologist of the…
VHIO cordinates the EU-funded PragmaTIL project. funded by the EU. The initiative brings together 12 institutions from 6 countries with…
Results of a VHIO led study show that up to 90% of chronically hypoxic patients have an EPAS1 alteration in…
Published in the journal Nature Communications*, results from a first-in-human, phase I clinical trial of an oral, potent and reversible…
Co-authored by investigators of VHIO’s Cancer Genomics Group and Research Unit for Molecular Therapy of Cancer (UITM) – CaixaResearch, results…
From the laboratory to the patient: the ”la Caixa” Foundation promotes 29 biomedicine and health projects The ”la Caixa” Foundation…
Published by ESMO’s Daily Reporter, Elena Garralda’s latest On target column explores the promise of neoadjuvant immunotherapy in the treatment…
